Press Release: Gritstone Bio : Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure
Voluntarily Files for Chapter 11 Restructuring Strategic Alternatives Process Continues with Interest from Parties EMERYVILLE, Calif.--(BUSINESS WIRE)-- Gritstone bio, Inc. (Nasdaq:...
Read full article »
Gritstone Bio is a California-based biotechnology company that develops and commercializes immunotherapies for the treatment of cancer and infectious diseases.
Read more